Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007

Journal of Clinical Oncology

Volumn 28, Issue 20, 2010, Pages 3299-3306

  Segawa, Yoshihiko ^a   Kiura, Katsuyuki ^a   Takigawa, Nagio ^a   Kamei, Haruhito ^a   Harita, Shingo ^a   Hiraki, Shunkichi ^a   Watanabe, Yoichi ^a   Sugimoto, Keisuke ^a   Shibayama, Takuo ^a   Yonei, Toshiro ^a   Ueoka, Hiroshi ^a   Takemoto, Mitsuhiro ^a   Kanazawa, Susumu ^a   Takata, Ichiro ^a   Nogami, Naoyuki ^a   Hotta, Katsuyuki ^a   Hiraki, Akio ^a   Tabata, Masahiro ^a   Matsuo, Keitaro ^a   Tanimoto, Mitsune ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; MITOMYCIN; VINDESINE; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DYSPHAGIA; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LOG RANK TEST; LUNG INFILTRATE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM METASTASIS; TAXOIDS; VINDESINE;

EID: 77954722629     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.7577     Document Type: Article

References (30)

1. Jemal A, Thun MJ, Ries LA, et al: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100:1672-1694, 2008
2. Kiura K, Takigawa N, Segawa Y, et al: Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small-cell lung cancer: A phase I/II trial. J Thorac Oncol 2:44-50, 2007 (Pubitemid 47163928)
3. Takigawa N, Kiura K, Segawa Y, et al: Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Br J Cancer 95:1142-1144, 2006 (Pubitemid 44658475)
4. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940-945, 1990 (Pubitemid 20332333)
5. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
6. Dritschilo A, Piro AJ, Kelman AD: The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. Int J Radiat Oncol Biol Phys 5:1345-1349, 1979 (Pubitemid 10130863)
7. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-530, 1992
8. Tannock IF: Treatment of cancer with radiation and drugs. J Clin Oncol 14:3156-3174, 1996
9. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999 (Pubitemid 29415225)
10. Curran WJ, Scott CB, Langer CJ, et al: Longterm benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22:621, 2003 (suppl; abstr 2499)
11. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, Version 2.2009. http://www.nccn.org
12. Masters GA, Haraf DJ, Hoffman PC, et al: Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol 16:2157-2163, 1998 (Pubitemid 28265053)
13. Choy H, Devore RF 3rd, Hande KR, et al: A phase II study of paclitaxel, carboplatin, and hyper-fractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). Int J Radiat Oncol Biol Phys 47:931-937, 2000 (Pubitemid 30345590)
14. Yamada M, Kudoh S, Fukuda H, et al: Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Br J Cancer 87:258-263, 2002
15. Kiura K, Ueoka H, Segawa Y, et al: Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer. Br J Cancer 89:795-802, 2003 (Pubitemid 37175797)
16. Vokes EE, Herndon JE 2nd, Crawford J, et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B Study 9431. J Clin Oncol 20:4191-4198, 2002 (Pubitemid 35191021)
17. Gandara DR, Chansky K, Albain KS, et al: Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 21:2004-2010, 2003
18. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
19. Kubota K, Watanabe K, Kunitoh H, et al: Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese Taxotere Lung Cancer Study Group. J Clin Oncol 22:254-261, 2004 (Pubitemid 41095089)
20. Rudd RM, Gower NH, Spiro SG, et al: Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group. J Clin Oncol 23:142-153, 2005 (Pubitemid 41702633)
21. Belani CP, Choy H, Bonomi P, et al: Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23:5883-5891, 2005
22. Vokes EE, Herndon JE 2nd, Kelley MJ, et al: Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25:1698-1704, 2007 (Pubitemid 46797950)
23. Hanna N, Neubauer M, Yiannoutsos C, et al: Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755-5760, 2008
24. Satouchi M, Yamamoto N, Chiba Y, et al: Randomized, phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin or weekly paclitaxel/carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer: WJTOG0105. J Clin Oncol 27:15s, 2009 (suppl; abstr 7504)
25. Fleming TR, Harrington DP, O'Brien PC: Designs for group sequential tests. Control Clin Trials 5:348-361, 1984 (Pubitemid 15175662)
26. Graham MV, Purdy JA, Emami B, et al: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323-329, 1999 (Pubitemid 29408545)
27. Albain KS, Crowley JJ, Turrisi AT 3rd, et al: Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20:3454-3460, 2002
28. Gandara DR, Vallières E, Gaspar LE, et al: Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: Rationale for consolidation docetaxel therapy. Clin Lung Cancer 7:S93-S97, 2005 (suppl 3) (Pubitemid 43285571)
29. Kimura T, Uejima H, Satouchi M, et al: J Clin Oncol 25:18s, 2007 (suppl; abstr 7530)
30. Katayama H, Ueoka H, Kiura K, et al: Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer 90:979-984, 2004 (Pubitemid 38495815)